LI Ruo-meng, ZHAO Lin-lin, WANG Dong-sheng. Meta-analysis on Yinchen Wulin Powder in Treating Hyperlipidemia[J]. Chinese journal of experimental traditional medical formulae, 2015, 21(15): 197-201.
DOI:
LI Ruo-meng, ZHAO Lin-lin, WANG Dong-sheng. Meta-analysis on Yinchen Wulin Powder in Treating Hyperlipidemia[J]. Chinese journal of experimental traditional medical formulae, 2015, 21(15): 197-201. DOI: 10.13422/j.cnki.syfjx.2015150197.
Meta-analysis on Yinchen Wulin Powder in Treating Hyperlipidemia
Objective: To evaluate the effect of Yinchen Wulin powder in treating hyperlipidemia. Method: Randomized control trials for studying the effect of Yinchen Wulin powder in treating hyperlipidemia from January 2000 to January 2013 were retrieved from the Cochrane library
Pubmed
CNKI
Wanfang and VIP database. The inclusion and exclusion standards were followed in screening literatures
extracting materials and evaluating their quality. The study results of the included literatures were analyzed by RevMan 5.2. Result: Totally 10 RCTs were included and involved 711 patients. According to the the results of the Meta-analysis
compared with the control group
the total effective rate of the treatment group increased. In decreasing the cholesterol (TC)
Yinchen Wulin powder was similar to statins and betts and superior to other Chinese patent lipid lowering medicines or other intervention factors. In decreasing the triglyceride (TG)
Yinchen Wulin powder was superior to statins and other factors and was similar to betts. In increasing the high density lipoprotein (HDL)
Yinchen Wulin powder was superior to betts and other factors
and similar to Statins. In decreasing the low density lipoprotein (LDL)
Yinchen Wulin powder was superior to betts and other factors
and only next to Statins. Conclusion: Yinchen Wulin powder has a better efficiency in treating hyperlipidemia.
Systematic Evaluation of Pushen Capsule in the Treatment of Hyperlipidemia: A Meta-analysis
Clinical Efficacy of Zhuyuwan in Treatment of Hyperlipidemia with Syndrome of Phlegm Turbidity and Obstruction
Zhuyuwan in Treatment of Hyperlipidemia Complicated with Carotid Atherosclerosis: A Randomized Controlled Trial
Mechanism of Wendantang in Intervention of ApoE-/- Hyperlipidemic Mice Based on Liver Metabolomics
Meta-analysis and Grade Evidence Evaluation of Qi-reinforcing and Blood-activating/ Stasis-expelling Chinese Patent Medicines in Treatment of Coronary Microvascular Disease
Related Author
Hui-min LI
Rui-xue HU
Ze-qi DAI
Si-min XU
Jing HU
Xing LIAO
YANG Lele
LUO Danmei
Related Institution
Institute of Basic Research in Clinical Medicine,China Academy of Chinese Medical Sciences
Beijing Hospital of Traditional Chinese Medicine(TCM) Affiliated to Capital Medical University, Evidence-based Medicine Center,Beijing Institute of TCM
Hospital of Chengdu University of Traditional Chinese Medicine (TCM)
Chengdu University of TCM
Chengdu University of Traditional Chinese Medicine(TCM)